Peroxisome proliferator–activated receptor-γ agonist rosiglitazone reduces clinical inflammatory responses in type 2 diabetes with coronary artery disease after coronary angioplasty

✍ Scribed by Guang Wang; Jinru Wei; Youfei Guan; Nan Jin; Jieming Mao; Xian Wang

• Book ID: 116747008
• Publisher: Elsevier Science
• Year: 2005
• Tongue: English
• Weight: 211 KB
• Volume: 54
• Category: Article
• ISSN: 1532-8600
• DOI: 10.1016/j.metabol.2004.11.017